Search Results

RBC8 25 mg  | 99.81%

TargetMol

RBC8 is a specific GTPases RalA/RalB inhibitor by inhibiting the binding of Ral to its effector RALBP1, no inhibition on the GTPases RhoA and Ras.

More Information Supplier Page

RBC8 50 mg  | 99.81%

TargetMol

RBC8 is a specific GTPases RalA/RalB inhibitor by inhibiting the binding of Ral to its effector RALBP1, no inhibition on the GTPases RhoA and Ras.

More Information Supplier Page

Retapamulin 5 mg  | 99.82%

TargetMol

Retapamulin, a Pleuromutilin Antibacterial, binds to both E. coli and S. aureus ribosomes with similar potencies (Kd: 3 nM).

More Information Supplier Page

SB-705498 1 mg  | 98.00%

TargetMol

SB705498 is a TRPV1 antagonist for hTRPV1. SB-705498 has been investigated for the treatment of Rhinitis, Chronic Cough, and Non-allergic Rhinitis.

More Information Supplier Page

Clinofibrate 100 mg  | Purity Not Available

TargetMol

Clinofibrate（IC50 of 0.47 mM）, a lipid-lowering agent, inhibits hydroxymethylglutaryl coenzyme A reductase (HMGCR). It is utilized to control high cholesterol and triacylglyceride levels in the blood.

More Information Supplier Page

Clinofibrate 25 mg  | Purity Not Available

TargetMol

Clinofibrate（IC50 of 0.47 mM）, a lipid-lowering agent, inhibits hydroxymethylglutaryl coenzyme A reductase (HMGCR). It is utilized to control high cholesterol and triacylglyceride levels in the blood.

More Information Supplier Page

Brimonidine Tartrate 100 mg  | 99.83%

TargetMol

Brimonidine Tartrate (AGN190342 tartrate) is a quinoxaline derivative and adrenergic α-2 receptor agonist (EC50: 0.45 nM) that is used to manage intraocular pressure associated with open-angle glaucoma or ocular hypertension.

More Information Supplier Page

Amprenavir 100 mg  | 99.79%

TargetMol

Amprenavir is a synthetic derivative of hydroxyethylamine sulfonamide that selectively binds to and inhibits human immunodeficiency virus (HIV) protease.

More Information Supplier Page